POLE and cancer: In a study performed by the TCGA, 17 cancers classified as ultramutated had a POLE EDM, including the most frequent P286R (exon 9) and V411L (exon 13) substitutions (eight and five cases, respectively) and one case each of M444K, A456P, L424I, and S297F substitutions.